Applicator preferences for subcutaneous biologics in inflammatory bowel disease: influence on patient satisfaction and willingness to switch treatment
The type of applicator was determined as important for patients, as they would consider changing it if other applicators were presented to them before the start of therapy. Thus, before choosing a subcutaneous biosimilar it would be reasonable to present all types of applicators to patients to individually select the most suitable one.
Authors
- Gregor Novak (ORCID: https://orcid.org/0000-0002-9110-9188)
- Ana Janeva
- Dušica Prodanova
- David Drobne
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1097/meg.0000000000003103
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00